An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy.
作者信息
Wood Deborah, Wesselschmidt Robin, Hematti Peiman, Gee Adrian P, Rooney Cliona, Silberstein Leslie, Armant Myriam, Couture Larry, Wagner John E, McKenna David H, Hei Derek, Mondoro Traci Heath, Welniak Lisbeth, Lindblad Robert
机构信息
The EMMES Corporation, Rockville, Maryland, USA.
出版信息
Clin Transl Sci. 2014 Apr;7(2):93-9. doi: 10.1111/cts.12148. Epub 2014 Mar 21.
Abstract
摘要
相似文献
1
An update from the United States National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: a decade of cell therapy.美国国立心肺血液研究所资助的细胞治疗生产援助（PACT）项目的最新情况：细胞治疗的十年。
Clin Transl Sci. 2014 Apr;7(2):93-9. doi: 10.1111/cts.12148. Epub 2014 Mar 21.
2
The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood Diseases.美国国立卫生研究院 SMARTT 计划：促进心肺血液疾病转化研究的新方法。
Circ Res. 2016 Jun 10;118(12):1867-71. doi: 10.1161/CIRCRESAHA.116.308550.
3
How one program at the National Heart, Lung, and Blood Institute establishes its scientific priorities.美国国立心肺血液研究所的一个项目是如何确定其科学重点的。
J Am Coll Cardiol. 2009 Jun 16;53(24):2259-61. doi: 10.1016/j.jacc.2009.03.024.
4
The National Heart, Lung, and Blood Institute-funded Production Assistance for Cellular Therapies (PACT) program: Eighteen years of cell therapy.美国国立心肺血液研究所资助的细胞治疗生产援助 (PACT) 计划：18 年的细胞治疗。
Clin Transl Sci. 2021 Nov;14(6):2099-2110. doi: 10.1111/cts.13102. Epub 2021 Jul 19.
5
Translation of genetics research to clinical medicine: the National Heart, Lung, and Blood Institute perspective.遗传学研究向临床医学的转化：美国国立心肺血液研究所的观点
Circ Cardiovasc Genet. 2013 Dec;6(6):634-9. doi: 10.1161/CIRCGENETICS.113.000227.
6
Funding mechanisms and program management at the National Heart, Lung, and Blood Institute: confronting new challenges and exploring new opportunities.美国国立心肺血液研究所的资助机制与项目管理：应对新挑战与探索新机遇
Circulation. 2011 Oct 25;124(17):1894-6. doi: 10.1161/CIRCULATIONAHA.111.065169.
7
Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program.细胞治疗产品的给药与安全性：来自细胞疗法生产援助（PACT）项目的数据收集与分析
Transfusion. 2015 Mar;55(3):674-9. doi: 10.1111/trf.12881. Epub 2014 Oct 14.
8
Production Assistance for Cellular Therapies (PACT): four-year experience from the United States National Heart, Lung, and Blood Institute (NHLBI) contract research program in cell and tissue therapies.细胞疗法生产援助项目（PACT）：来自美国国立心肺血液研究所（NHLBI）细胞与组织疗法合同研究项目的四年经验。
Transfusion. 2009 Apr;49(4):786-96. doi: 10.1111/j.1537-2995.2008.02027.x. Epub 2008 Dec 23.
9
Angiogenesis Research: Extramural Portfolio Supported by the National Heart, Lung, and Blood Institute, 2008-2015.血管生成研究：由美国国立心肺血液研究所支持的机构外项目组合，2008 - 2015年
Circ Res. 2017 May 26;120(11):1713-1717. doi: 10.1161/CIRCRESAHA.117.310735.
10
National Heart, Lung, and Blood Institute and the American Recovery and Reinvestment Act of 2009: 1 year later.美国国立心肺血液研究所与《2009年美国复苏与再投资法案》：一年之后
J Am Coll Cardiol. 2010 Jul 13;56(3):234-6. doi: 10.1016/j.jacc.2010.03.042.
引用本文的文献
1
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019.2019年肺生物学与疾病中的干细胞、细胞疗法及生物工程
ERJ Open Res. 2020 Oct 19;6(4). doi: 10.1183/23120541.00123-2020. eCollection 2020 Oct.
2
A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.一种用于测量间充质基质细胞介导的T细胞抑制作用的可重复性免疫效力测定法。
Cytotherapy. 2015 Feb;17(2):140-51. doi: 10.1016/j.jcyt.2014.10.002. Epub 2014 Nov 21.
3
Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) program.细胞治疗产品的给药与安全性：来自细胞疗法生产援助（PACT）项目的数据收集与分析
Transfusion. 2015 Mar;55(3):674-9. doi: 10.1111/trf.12881. Epub 2014 Oct 14.
本文引用的文献
1
Strategies for more rapid translation of cellular therapies for children: a US perspective.促进儿童细胞治疗更快转化的策略：美国视角。
Pediatrics. 2013 Aug;132(2):351-8. doi: 10.1542/peds.2012-3383. Epub 2013 Jul 8.
2
Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant.同种异体造血干细胞移植后，三病毒靶向 T 细胞快速生成治疗腺病毒、EBV 和 CMV 感染的安全性和临床疗效。
Mol Ther. 2013 Nov;21(11):2113-21. doi: 10.1038/mt.2013.151. Epub 2013 Jun 20.
3
Wiskott-Aldrich syndrome: a comprehensive review.威斯科特-奥尔德里奇综合征：全面综述。
Ann N Y Acad Sci. 2013 May;1285:26-43. doi: 10.1111/nyas.12049. Epub 2013 Mar 25.
4
Manufacturing mesenchymal stromal cells for phase I clinical trials.用于 I 期临床试验的间充质基质细胞的制造。
Cytotherapy. 2013 Apr;15(4):416-22. doi: 10.1016/j.jcyt.2012.09.007.
5
Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.人骨髓间充质干细胞对活体细菌致体外人肺损伤的治疗作用。
Am J Respir Crit Care Med. 2013 Apr 1;187(7):751-60. doi: 10.1164/rccm.201206-0990OC.
6
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.骨髓单个核细胞应用时间和方式对急性心肌梗死后左心室功能的影响：TIME 随机试验。
JAMA. 2012 Dec 12;308(22):2380-9. doi: 10.1001/jama.2012.28726.
7
Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.快速产生的多种病毒特异性细胞毒性 T 淋巴细胞，用于预防和治疗病毒感染。
Mol Ther. 2012 Aug;20(8):1622-32. doi: 10.1038/mt.2012.130. Epub 2012 Jul 17.
8
Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions.自体干细胞移植受者可耐受单倍体相合相关供者自然杀伤细胞富集输注。
Transfusion. 2013 Feb;53(2):412-8; quiz 411. doi: 10.1111/j.1537-2995.2012.03764.x. Epub 2012 Jun 28.
9
Successful "in-flight" activation of natural killer cells during long-distance shipping.在长途运输过程中成功地“飞行中”激活自然杀伤细胞。
Transfusion. 2013 Feb;53(2):398-403. doi: 10.1111/j.1537-2995.2012.03695.x. Epub 2012 May 11.
10
Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant.生产符合良好生产规范的、针对 Epstein-Barr 病毒、巨细胞病毒和腺病毒的细胞毒性 T 淋巴细胞，以预防或治疗异基因造血干细胞移植后病毒感染。
Cytotherapy. 2012 Jan;14(1):7-11. doi: 10.3109/14653249.2011.636963.
Zotero 插件